Beximco Pharmaceuticals, a pharmaceutical company in Bangladesh, agreed to acquire a 54.6% stake in Sanofi Bangladesh, a pharmaceutical company, for £35m. "We are delighted to announce our intention to acquire a majority stake in Sanofi Bangladesh. If approved, it will be the second strategic acquisition in the Company's history, following that of Nuvista Pharma Limited in 2018, and is testament to our continued commitment to delivering affordable treatments and breakthrough therapies to the growing market in Bangladesh. Sanofi Bangladesh has an established reputation for high quality products, with the acquisition expanding and strengthening our position in key therapeutic areas to drive sustainable revenue and profit growth," Nazmul Hassan, Beximco Pharma Managing Director.